未登录

I

Irina Budunova

northwestern university

H指数:29

被引数:2,648

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Skin as a Potential Entry Point for SARS-CoV-2 Virus

皮肤作为SARS-CoV-2病毒潜在的入侵点

International Journal of Molecular Sciences

IF4.9

2026-06-150

OA

Skin microbiota differs between Black and White patients with cutaneous T-cell lymphoma

皮肤微生物组在患有皮肤T细胞淋巴瘤的黑人和白人患者之间存在差异

Journal of the American Academy of Dermatology

IF11.8

2025-08-220

PRE

REDD1 (regulated in development and DNA damage 1) modulates the glucocorticoid receptor function in keratinocytes

EXPERIMENTAL DERMATOLOGY

IF3.1

2023-07-230

OAAI

Transcriptome Analysis Reveals Intrinsic Proinflammatory Signaling in Healthy African American Skin

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2022-05-019

OAAI

Roles Played by Stress-Induced Pathways in Driving Ethnic Heterogeneity for Inflammatory Skin Diseases

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-04-282

OAAI

Early Stress-Response Gene REDD1 Controls Oxazolone-Induced Allergic Contact Dermatitis

JOURNAL OF IMMUNOLOGY

IF3.4

2021-10-014

OA

A Novel Approach to Safer Glucocorticoid Receptor-Targeted Anti-lymphoma Therapy via RED D1 (Regulated in Development and DNA Damage 1) Inhibition

MOLECULAR CANCER THERAPEUTICS

IF5.5

2020-09-025

OAAI

Regulated in Development and DNA Damage Responses 1 Prevents Dermal Adipocyte Differentiation and Is Required for Hair Cycle-Dependent Dermal Adipose Expansion

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2020-09-017

OAAI

Transcriptomic Network Interactions in Human Skin Treated with Topical Glucocorticoid Clobetasol Propionate

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2019-11-0118

OAAI

PI3-Kinase inhibitors represent a novel class of drug repurposing candidates to prevent glucocorticoid-induced skin atrophy

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2019-09-010

OAAI

Novel transcriptomic network interactions in the human skin treated with topical glucocorticoid

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2019-09-010

OAAI

PI3K inhibitors protect against glucocorticoid-induced skin atrophy

IF10.8

2019-03-0121

OAAI

Rapamycin Modulates Glucocorticoid Receptor Function, Blocks Atrophogene REDD1, and Protects Skin from Steroid Atrophy

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2018-09-0124

OAAI

The gluciocorticoid receptor is a master regulator of transcription in human skin

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2018-05-010

OAAI

Endogenous Glucocorticoid Deficiency in Psoriasis Promotes Inflammation and Abnormal Differentiation

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2017-07-0139

OAAI

Metabolomic profiling of psoriasis skin reveals localized cortisol deficiency resulting in maintenance of inflammatory state and disruption of epidermal differentiation

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2017-05-010

OAAI

PI3-Kinase inhibitors represent a novel class of drug repurposing candidates to prevent/alleviate glucocorticoid-induced skin atrophy

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2017-05-010

OAAI

Sexual dimorphism in adverse effects of topical glucocorticoids is driven by the differential regulation of atrophogene REDD1 in male and female skin

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2017-05-010

OAAI

N-bromotaurine surrogates for loss of antiproliferative response and enhances cisplatin efficacy in cancer cells with impaired glucocorticoid receptor

TRANSLATIONAL RESEARCH

IF5.9

2016-07-016

PREAI

Topical application of anti-cancer drug Bortezomib stimulates proliferation of follicular cells and induces expression of hair keratins via GATA-3 transcription factor

JOURNAL OF INVESTIGATIVE DERMATOLOGY

IF5.7

2016-05-010

OAAI